vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Xometry, Inc. (XMTR). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $192.4M, roughly 1.9× Xometry, Inc.). AdvanSix Inc. runs the higher net margin — -0.8% vs -4.5%, a 3.7% gap on every dollar of revenue. On growth, Xometry, Inc. posted the faster year-over-year revenue change (29.5% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-5.9M). Over the past eight quarters, Xometry, Inc.'s revenue compounded faster (25.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Xometry is an online marketplace for sourcing on-demand manufactured parts for prototyping and large-scale production.
ASIX vs XMTR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $192.4M |
| Net Profit | $-2.8M | $-8.6M |
| Gross Margin | 7.6% | 39.1% |
| Operating Margin | -0.7% | -4.6% |
| Net Margin | -0.8% | -4.5% |
| Revenue YoY | 9.4% | 29.5% |
| Net Profit YoY | -892.9% | 12.7% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $192.4M | ||
| Q3 25 | $374.5M | $180.7M | ||
| Q2 25 | $410.0M | $162.5M | ||
| Q1 25 | $377.8M | $151.0M | ||
| Q4 24 | $329.1M | $148.5M | ||
| Q3 24 | $398.2M | $141.7M | ||
| Q2 24 | $453.5M | $132.6M | ||
| Q1 24 | $336.8M | $122.7M |
| Q4 25 | $-2.8M | $-8.6M | ||
| Q3 25 | $-2.6M | $-11.6M | ||
| Q2 25 | $31.4M | $-26.4M | ||
| Q1 25 | $23.3M | $-15.1M | ||
| Q4 24 | $352.0K | $-9.9M | ||
| Q3 24 | $22.3M | $-10.2M | ||
| Q2 24 | $38.9M | $-13.7M | ||
| Q1 24 | $-17.4M | $-16.6M |
| Q4 25 | 7.6% | 39.1% | ||
| Q3 25 | 6.8% | 39.9% | ||
| Q2 25 | 14.3% | 40.1% | ||
| Q1 25 | 14.2% | 37.3% | ||
| Q4 24 | 3.4% | 39.7% | ||
| Q3 24 | 14.4% | 39.4% | ||
| Q2 24 | 17.9% | 39.9% | ||
| Q1 24 | 0.9% | 39.0% |
| Q4 25 | -0.7% | -4.6% | ||
| Q3 25 | -0.9% | -6.1% | ||
| Q2 25 | 7.7% | -6.3% | ||
| Q1 25 | 7.7% | -10.2% | ||
| Q4 24 | -3.9% | -7.8% | ||
| Q3 24 | 7.5% | -8.1% | ||
| Q2 24 | 11.5% | -11.5% | ||
| Q1 24 | -7.0% | -14.6% |
| Q4 25 | -0.8% | -4.5% | ||
| Q3 25 | -0.7% | -6.4% | ||
| Q2 25 | 7.7% | -16.3% | ||
| Q1 25 | 6.2% | -10.0% | ||
| Q4 24 | 0.1% | -6.7% | ||
| Q3 24 | 5.6% | -7.2% | ||
| Q2 24 | 8.6% | -10.3% | ||
| Q1 24 | -5.2% | -13.5% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.43 | — | ||
| Q1 24 | $-0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $219.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $275.6M |
| Total Assets | $1.7B | $703.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $219.1M | ||
| Q3 25 | $23.7M | $224.5M | ||
| Q2 25 | $18.4M | $225.8M | ||
| Q1 25 | $8.3M | $231.4M | ||
| Q4 24 | $19.6M | $239.8M | ||
| Q3 24 | $17.3M | $234.0M | ||
| Q2 24 | $12.1M | $240.9M | ||
| Q1 24 | $20.6M | $253.8M |
| Q4 25 | $815.2M | $275.6M | ||
| Q3 25 | $818.2M | $272.0M | ||
| Q2 25 | $823.7M | $270.4M | ||
| Q1 25 | $794.4M | $309.9M | ||
| Q4 24 | $774.6M | $314.5M | ||
| Q3 24 | $766.4M | $315.2M | ||
| Q2 24 | $746.6M | $315.8M | ||
| Q1 24 | $713.2M | $320.4M |
| Q4 25 | $1.7B | $703.7M | ||
| Q3 25 | $1.7B | $698.9M | ||
| Q2 25 | $1.6B | $687.0M | ||
| Q1 25 | $1.6B | $690.1M | ||
| Q4 24 | $1.6B | $680.1M | ||
| Q3 24 | $1.5B | $678.2M | ||
| Q2 24 | $1.5B | $678.6M | ||
| Q1 24 | $1.5B | $692.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $4.4M |
| Free Cash FlowOCF − Capex | $36.1M | $-5.9M |
| FCF MarginFCF / Revenue | 10.0% | -3.0% |
| Capex IntensityCapex / Revenue | 7.7% | 5.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-24.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $4.4M | ||
| Q3 25 | $26.6M | $5.8M | ||
| Q2 25 | $21.1M | $-427.0K | ||
| Q1 25 | $11.4M | $-3.7M | ||
| Q4 24 | $64.2M | $9.1M | ||
| Q3 24 | $57.3M | $-3.6M | ||
| Q2 24 | $50.2M | $-9.1M | ||
| Q1 24 | $-36.2M | $-11.7M |
| Q4 25 | $36.1M | $-5.9M | ||
| Q3 25 | $66.0K | $-1.7M | ||
| Q2 25 | $-7.2M | $-7.4M | ||
| Q1 25 | $-22.6M | $-9.2M | ||
| Q4 24 | $29.8M | $4.5M | ||
| Q3 24 | $26.8M | $-8.4M | ||
| Q2 24 | $16.7M | $-13.5M | ||
| Q1 24 | $-71.6M | $-16.1M |
| Q4 25 | 10.0% | -3.0% | ||
| Q3 25 | 0.0% | -0.9% | ||
| Q2 25 | -1.7% | -4.5% | ||
| Q1 25 | -6.0% | -6.1% | ||
| Q4 24 | 9.1% | 3.1% | ||
| Q3 24 | 6.7% | -6.0% | ||
| Q2 24 | 3.7% | -10.2% | ||
| Q1 24 | -21.3% | -13.1% |
| Q4 25 | 7.7% | 5.3% | ||
| Q3 25 | 7.1% | 4.1% | ||
| Q2 25 | 6.9% | 4.3% | ||
| Q1 25 | 9.0% | 3.6% | ||
| Q4 24 | 10.4% | 3.1% | ||
| Q3 24 | 7.7% | 3.4% | ||
| Q2 24 | 7.4% | 3.3% | ||
| Q1 24 | 10.5% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
XMTR
| US | $159.1M | 83% |
| Non Us | $33.3M | 17% |
